Literature DB >> 21887676

Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.

Sunil Amin1, Russell B McBride, Jennie K Kline, Elana B Mitchel, Aimee L Lucas, Alfred I Neugut, Harold Frucht.   

Abstract

BACKGROUND: Several environmental risk factors are known to predispose individuals to pancreatic cancer, and up to 15% of pancreatic cancers have an inherited component. Understanding metachronous cancer associations can modify pancreas cancer risk. The objective of this study was to investigate the association of nonpancreatic cancers with subsequent pancreatic adenocarcinoma.
METHODS: The authors used data from the US Surveillance, Epidemiology, and End Results (SEER) registries to identify 1,618,834 individuals who had a primary malignancy and subsequent pancreatic adenocarcinoma (n = 4013). Standardized incidence ratios were calculated as an approximation of relative risk (RR) for the occurrence of pancreatic adenocarcinoma after another primary malignancy.
RESULTS: Among patients who were diagnosed with a first primary malignancy at ages 20 to 49 years, the risk of subsequent pancreatic adenocarcinoma was increased among patients who had cancers of the ascending colon (relative risk [RR], 4.62; 95% confidence interval [CI], 1.86-9.52), hepatic flexure (RR, 5.42; 95% CI, 1.12-15.84), biliary system (RR, 13.14; 95% CI, 4.27-30.66), breast (RR, 1.32; 95% CI, 1.09-1.59), uterine cervix (RR, 1.61; 95% CI, 1.02-2.41), testes (RR, 2.78; 95% CI, 1.83-4.05), and hematopoietic system (RR, 1.83; 95% CI, 1.28-2.53). Among patients who had a first malignancy at ages 50 to 64 years, the risk was increased after cancers of the stomach (RR, 1.88; 95% CI, 1.13-2.93), hepatic flexure (RR, 2.25; 95% CI, 1.08-4.13), lung and bronchus (RR, 1.46; 95% CI, 1.16-1.82), pharynx (RR, 2.26; 95% CI, 1.13-4.04), and bladder (RR, 1.24; 95% CI, 1.03-1.48). Among patients who had a primary cancer after age 65 years, the risk was increased after cancers of the stomach (RR, 1.79; 95% CI, 1.23-2.53), hepatic flexure (RR, 1.76; 95% CI, 1.06-2.75), biliary system (RR, 2.35; 95% CI, 1.17-4.20), and uterus (RR, 1.23; 95% CI, 1.03-1.47).
CONCLUSIONS: The results from the current population-based data set suggested that pancreatic adenocarcinoma is associated with certain primary cancers. Genetic predisposition and common environmental and behavioral risk factors all may contribute to this observation. Specific tumor associations will guide future risk-stratification efforts.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21887676      PMCID: PMC3677019          DOI: 10.1002/cncr.26414

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  49 in total

1.  Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Authors:  Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

2.  The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.

Authors:  M Schenk; R K Severson; K S Pawlish
Journal:  Cancer       Date:  1998-05-01       Impact factor: 6.860

3.  The prevalence of BRCA2 mutations in familial pancreatic cancer.

Authors:  Fergus J Couch; Michele R Johnson; Kari G Rabe; Kieran Brune; Mariza de Andrade; Michael Goggins; Heidi Rothenmund; Steven Gallinger; Alison Klein; Gloria M Petersen; Ralph H Hruban
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

4.  Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.

Authors:  J Lorenzo Bermejo; K Hemminki
Journal:  Ann Oncol       Date:  2004-12       Impact factor: 32.976

5.  Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.

Authors:  Robert R McWilliams; Kari G Rabe; Curtis Olswold; Mariza De Andrade; Gloria M Petersen
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

Review 6.  Management strategies for patients with hereditary pancreatic cancer.

Authors:  Teresa A Brentnall
Journal:  Curr Treat Options Oncol       Date:  2005-09

7.  Isoform-specific upregulation of palladin in human and murine pancreas tumors.

Authors:  Silvia M Goicoechea; Brian Bednarski; Christianna Stack; David W Cowan; Keith Volmar; Leigh Thorne; Edna Cukierman; Anil K Rustgi; Teresa Brentnall; Rosa F Hwang; Christopher A G McCulloch; Jen Jen Yeh; David J Bentrem; Steven N Hochwald; Sunil R Hingorani; Hong Jin Kim; Carol A Otey
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

8.  Risk of pancreatic cancer in families with Lynch syndrome.

Authors:  Fay Kastrinos; Bhramar Mukherjee; Nabihah Tayob; Fei Wang; Jennifer Sparr; Victoria M Raymond; Prathap Bandipalliam; Elena M Stoffel; Stephen B Gruber; Sapna Syngal
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

9.  BRCA2 germline mutations in familial pancreatic carcinoma.

Authors:  Stephan A Hahn; Bill Greenhalf; Ian Ellis; Mercedes Sina-Frey; Harald Rieder; Birgit Korte; Berthold Gerdes; Ralf Kress; Andreas Ziegler; John A Raeburn; Donata Campra; Robert Grützmann; Helga Rehder; Matthias Rothmund; Wolff Schmiegel; John P Neoptolemos; Detlef K Bartsch
Journal:  J Natl Cancer Inst       Date:  2003-02-05       Impact factor: 13.506

10.  Increased risk for cancer in patients with the Peutz-Jeghers syndrome.

Authors:  L A Boardman; S N Thibodeau; D J Schaid; N M Lindor; S K McDonnell; L J Burgart; D A Ahlquist; K C Podratz; M Pittelkow; L C Hartmann
Journal:  Ann Intern Med       Date:  1998-06-01       Impact factor: 25.391

View more
  12 in total

1.  Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study.

Authors:  Sojun Hoshimoto; Shoichi Hishinuma; Hirofumi Shirakawa; Moriaki Tomikawa; Iwao Ozawa; Yoshiro Ogata
Journal:  Langenbecks Arch Surg       Date:  2019-11-25       Impact factor: 3.445

2.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

3.  Trends in racial disparities in pancreatic cancer surgery.

Authors:  Anand Shah; K S Clifford Chao; Truls Ostbye; Anthony W Castleberry; Ricardo Pietrobon; Beat Gloor; Bryan M Clary; Rebekah R White; Mathias Worni
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

4.  Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study.

Authors:  Lishan Song; Chaojie Xu; Tong Zhang; Shengyang Chen; Zhigang Shi; Shuiquan Hu; Bingbing Cheng; Hao Tong; Guangkun Wei; Xiaoyong Li
Journal:  Front Surg       Date:  2022-08-30

5.  α-Mangostin suppresses human gastric adenocarcinoma cells in vitro via blockade of Stat3 signaling pathway.

Authors:  Tao Shan; Xi-juan Cui; Wei Li; Wan-run Lin; Hong-wei Lu; Yi-ming Li; Xi Chen; Tao Wu
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

6.  Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study.

Authors:  Kai Mao; Wen Jiang; Jieqiong Liu; Jie Wang
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

7.  Creation of gastric conduit free-graft with intraoperative perfusion imaging during pancreaticoduodenectomy in a patient post esophagectomy.

Authors:  Spyridon Pagkratis; Dimitrios Virvilis; Brett T Phillips; Philip Q Bao; Sami U Khan; Jason C Ganz; Kevin T Watkins
Journal:  Int J Surg Case Rep       Date:  2015-02-19

8.  Clinical characteristics of second primary pancreatic cancer.

Authors:  Jung Hyun Jo; In Rae Cho; Jang Han Jung; Hee Seung Lee; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Jae Bock Chung; Si Young Song; Jeong Youp Park
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

9.  The impact of a history of cancer on pancreatic ductal adenocarcinoma survival.

Authors:  Xingkang He; Yue Li; Tingting Su; Sanchuan Lai; Wenrui Wu; Luyi Chen; Jianmin Si; Leimin Sun
Journal:  United European Gastroenterol J       Date:  2018-04-30       Impact factor: 4.623

10.  Different Anatomical Subsites of Colon Cancer and Mortality: A Population-Based Study.

Authors:  Xing-Kang He; Wenrui Wu; Yu-E Ding; Yue Li; Lei-Min Sun; Jianmin Si
Journal:  Gastroenterol Res Pract       Date:  2018-08-30       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.